OSTM1

Chr 6AR

osteoclastogenesis associated transmembrane protein 1

OSTM1 encodes a protein with E3 ubiquitin ligase activity that degrades G proteins via the ubiquitin-proteasome pathway and is required for osteoclast and melanocyte maturation and function. Mutations cause autosomal recessive osteopetrosis with infantile malignant onset, affecting bone remodeling and potentially melanocyte function. This follows autosomal recessive inheritance.

OMIMResearchSummary from RefSeq, OMIM, UniProt
MultiplemechanismARLOEUF 0.741 OMIM phenotype
Clinical SummaryOSTM1
🧬
Gene-Disease Validity (ClinGen)
autosomal recessive osteopetrosis 5 · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Low constraint (pLI 0.01) — loss-of-function variants are relatively tolerated in the population.
Some data sources returned errors (1)

ncbi: Error: NCBI fetch failed: 429 https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esearch.fcgi

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
0.74LOEUF
pLI 0.011
Z-score 2.33
OE 0.37 (0.200.74)
Tolerant

Typical tolerance to LoF variation

Missense Constraint
1.09Z-score
OE missense 0.77 (0.670.89)
139 obs / 180.3 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.37 (0.200.74)
00.351.4
Missense OE0.77 (0.670.89)
00.61.4
Synonymous OE0.99
01.21.6
LoF obs/exp: 6 / 16.1Missense obs/exp: 139 / 180.3Syn Z: 0.05
DN
0.6939th %ile
GOF
0.77top 25%
LOF
0.2680th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

OSTM1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →